In a retrospective analysis, it was observed that DMGs with mutations in both H3K27-altered and TP53 exhibit increased resistance to radiation therapy, enhanced tumor aggressiveness, and worse overall survival compared to patients without these mutations or with only one mutation present [73]. This evidence concerns the gene TP53 and neoplasm.